Form 8-K - Current report:
SEC Accession No. 0001104659-18-051114
Filing Date
2018-08-10
Accepted
2018-08-10 11:36:55
Documents
3
Period of Report
2018-08-10
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-18646_18k.htm 8-K 23520
2 EX-99.1 a18-18646_1ex99d1.htm EX-99.1 15008
3 GRAPHIC g186461mmi001.jpg GRAPHIC 3518
  Complete submission text file 0001104659-18-051114.txt   44684
Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152 248-980-6538
Gemphire Therapeutics Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 181007722
SIC: 2834 Pharmaceutical Preparations